Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Does elevated homocysteine with normal B12, folate, and MMA suggest a remethylation bottleneck?

Elevated homocysteine with optimal vitamin B12, normal methylmalonic acid, and optimal folate points to a functional methylation or remethylation bottleneck rather than a simple vitamin deficiency.

PlausibleJuly 20, 202613 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Elevated homocysteine with optimal vitamin B12, normal methylmalonic acid, and optimal folate suggests a functional methylation or remethylation bottleneck rather than simple vitamin B12 or folate deficiency.

laying out figure…
0 of 2 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

This lab pattern is framed as a metabolic block in homocysteine remethylation, where homocysteine rises despite apparently adequate B12 and folate status. The mechanism emphasizes pathways that can limit homocysteine recycling, including folate-dependent remethylation, intracellular cobalamin handling, BHMT-related backup remethylation, and reduced renal clearance.

Verified conclusion

An elevated plasma homocysteine level in the presence of optimal folate, optimal vitamin B12, and normal methylmalonic acid (MMA) presents a distinct clinical scenario. Because normal MMA highly specifically rules out systemic vitamin B12 deficiency, this biomarker profile points directly to localized metabolic disruptions or clearance issues rather than a simple nutritional deficiency.

Mechanistic pathways and genetic bottlenecks

  • MTHFR Polymorphisms: Genetic variants such as MTHFR C677T impair the enzymatic reduction of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate (5-MTHF). This limits folate-dependent remethylation of homocysteine to methionine, even when serum folate levels appear optimal.
  • Intracellular Cobalamin Defects: Inborn errors of cobalamin metabolism, specifically the cblE and cblG complementation groups, selectively impair methionine synthase activity. This causes hyperhomocysteinemia while sparing the mitochondrial mutase pathway, leaving MMA levels normal.
  • BHMT Pathway Insufficiency: The alternative, B12-independent remethylation pathway in the liver relies on betaine-homocysteine S-methyltransferase (BHMT). Insufficient dietary intake of choline or betaine, or genetic variations in the BHMT enzyme, compromises this secondary pathway, leading to elevated homocysteine.

Renal and clearance factors

  • Impaired Renal Clearance: Beyond enzymatic bottlenecks, renal impairment or chronic kidney disease (CKD) is the most common non-nutritional cause of this profile. Reduced glomerular filtration directly limits the clearance and excretion of homocysteine, mimicking a metabolic block despite optimal vitamin status.

Bottom line

  • Elevated homocysteine with normal MMA and optimal B12/folate indicates a functional remethylation bottleneck—typically driven by MTHFR variants, intracellular cobalamin defects (cblE/cblG), BHMT/choline pathway insufficiency, or reduced renal clearance—rather than a simple dietary vitamin deficiency.

References

  1. Methionine synthase reductase deficiency (CblE): A report of two patients and a novel mutation — tandfonline.com ↗
  2. Guidelines for diagnosis and management of the cobalamin‐related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency — link.springer.com ↗
  3. Remethylation disorders — oaanews.org ↗
  4. Homocysteine, vitamin B12, folates, vitamin B6, choline, ... — clinical-laboratory-diagnostics.com ↗
  5. Betaine consumption as a new clinical approach to treatment and prophylaxis of folate-related pathologies. — academic.oup.com ↗
  6. Betaine supplementation decreases plasma homocysteine in healthy ... — pmc.ncbi.nlm.nih.gov ↗
  7. How do B vitamins affect homocysteine and brain/CV health? — nutritailor.co.uk ↗
  8. Methylmalonic Acid and Homocysteine as Indicators of ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  9. Mthfr Genotyping: When And... — healthrx.com ↗
  10. Causes of Elevated Homocysteine with Normal Folate, B12 ... — droracle.ai ↗
  11. What are the management options for a patient with ... - Dr.Oracle — droracle.ai ↗
  12. The BHMT-betaine methylation pathway epigenetically ... — journals.plos.org ↗
  13. Betaine and choline intakes are related to total plasma homocysteine: health survey of São Paulo, Brazil — onlineijcs.org ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible3 sourcesIs TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?→